A Phase II randomized multicenter placebo-controlled blinded study of sorafenib adjuvant therapy in high-risk liver transplant recipients with hepatocellular carcinoma Article

Web of Science: 001364808800006

Cited authors

  • Kimelman F, Maeda K, Thornley C, Montgomery R, Cameron A, Carmody I, Agrawal S, Olthoff KM, Nydam T, Florman S, Chapman W, Pearson T, Fishbein T, Duffy J, Cannon R, Ghobrial RM, Gumate S, Holt C, Saab S, Ebaid S, Agopian V, Farmer D, Finn R, Busuttil R, Kaldas F

Authors

Publication date

  • 2024

Published in

International Standard Serial Number (ISSN)

  • 1527-6465

Number of pages

  • 1

Start page

  • 7

End page

  • 7

Volume

  • 30